期刊文献+

Changes in biochemical parameters on the first day after kidney transplantation: risk factors for nosocomial infection? 被引量:4

Changes in biochemical parameters on the first day after kidney transplantation: risk factors for nosocomial infection?
原文传递
导出
摘要 Background Nosocomial infection in early post-transplantation period is a tough problem for kidney transplantation. Few reports have explored the relations between biochemical parameters and nosocomial infection in kidney transplantation. This retrospective study was carried out to describe the characteristics of nosocomial infection in the very early period of kidney transplantation and to determine the risk factors in biochemical parameters and their alterations. Methods Patients who underwent their first kidney transplantation from January 2001 to March 2009 in Beijing Chao-Yang Hospital were recruited and the nosocomial infectious episodes were collected for this study. Gender, age, donor type, delayed graft function (DGF) and biochemical parameters such as serum uric acid, lipids files and albumin on day 0 (before transplantation) and day 1 (24 hours after transplantation) and their changes were analyzed with Logistic regression models for nosocomial infection. Results A total of 405 patients (315 men and 90 women) were involved in this study. There were 80 patients experiencing 113 infection episodes and 105 strains of microorganism were indentified. In univariate analysis, there were significant differences in DGF, albumin on day 0, lipoprotein (a) (Lp(a)) on day 1, change in low density lipoprotein-cholesterol (LDL-C, day 1-day 0) and change in uric acid (day 1-day 0) between nosocomial infection patients and noninfectious patients (P 〈0.05). In multivariate analysis, change in uric acid (day 1-day 0) (OR 5.139, 95% CI 1.176-22.465, P 〈0.05), change in LDL-C (day 1-day 0) (OR4.179, 95% CI 1.375-12.703, P 〈0.05) and DGF (OR 14.409, 95% CI 1.603-129.522, P 〈0.05) were identified as independent risk factors for nosocomial infection in kidney transplantation. Conclusions Most nosocomial infections in early postoperative period of kidney transplantation are bacterial, especially with Gram-negative bacteria. The most common infection sites are respiratory tract, urinary tract and surgical site. DGF, decrease of LDL-C and increase of uric acid could increase the risk for nosocomial infections. Background Nosocomial infection in early post-transplantation period is a tough problem for kidney transplantation. Few reports have explored the relations between biochemical parameters and nosocomial infection in kidney transplantation. This retrospective study was carried out to describe the characteristics of nosocomial infection in the very early period of kidney transplantation and to determine the risk factors in biochemical parameters and their alterations. Methods Patients who underwent their first kidney transplantation from January 2001 to March 2009 in Beijing Chao-Yang Hospital were recruited and the nosocomial infectious episodes were collected for this study. Gender, age, donor type, delayed graft function (DGF) and biochemical parameters such as serum uric acid, lipids files and albumin on day 0 (before transplantation) and day 1 (24 hours after transplantation) and their changes were analyzed with Logistic regression models for nosocomial infection. Results A total of 405 patients (315 men and 90 women) were involved in this study. There were 80 patients experiencing 113 infection episodes and 105 strains of microorganism were indentified. In univariate analysis, there were significant differences in DGF, albumin on day 0, lipoprotein (a) (Lp(a)) on day 1, change in low density lipoprotein-cholesterol (LDL-C, day 1-day 0) and change in uric acid (day 1-day 0) between nosocomial infection patients and noninfectious patients (P 〈0.05). In multivariate analysis, change in uric acid (day 1-day 0) (OR 5.139, 95% CI 1.176-22.465, P 〈0.05), change in LDL-C (day 1-day 0) (OR4.179, 95% CI 1.375-12.703, P 〈0.05) and DGF (OR 14.409, 95% CI 1.603-129.522, P 〈0.05) were identified as independent risk factors for nosocomial infection in kidney transplantation. Conclusions Most nosocomial infections in early postoperative period of kidney transplantation are bacterial, especially with Gram-negative bacteria. The most common infection sites are respiratory tract, urinary tract and surgical site. DGF, decrease of LDL-C and increase of uric acid could increase the risk for nosocomial infections.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第5期563-568,共6页 中华医学杂志(英文版)
关键词 delayed graft function cholesterol low density lipoprotein cross infection kidney transplantation uric acid delayed graft function cholesterol, low density lipoprotein cross infection kidney transplantation uric acid
  • 相关文献

参考文献3

二级参考文献16

  • 1胡国芳,陈保生,杨晓慧,王树蕙.血浆载脂蛋白A-Ⅰ生理功能的研究──A-Ⅰ及其裂解片段对单纯疱疹病毒感染细胞的作用[J].中国医学科学院学报,1994,16(2):98-103. 被引量:3
  • 2Owens BJ,Anantharamaiah GM,Kahlon JB,et al.Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation[J].J Clin Invest,1990,86(4):1142-1150.
  • 3Martin I,Dubois MC,Saermark T,et al.Apolipoprotein A1 interacts with the N-terminal fusogenic domains of SIV (simian immunodeficiency virus) GP32 and HIV (human immunodeficiency virus) GP41:implications in viral entry[J].Biochem Biophys Res Commun,1992,186(1):95-101.
  • 4Panin LE,Kostina NE,Poteriaeva ON,et al.Immunochemical homology of HIV-1 envelope proteins and human apolipoprotein AI[J].Vopr Virusol,2001,46 (5):13-16.
  • 5Panin LE,Kostina NE.Interaction of human apolipoprotein AI and HIV-1 envelope proteins with the native and recombinant CD4 receptors[J].Vopr Virusol,2003,48(1):24-26.
  • 6Panin LE,Kostina NE.Interaction of human apolipoprotein A-I with rsCD4 receptor[J].Bull Exp Biol Med,2002,133 (4):342-343.
  • 7Constans J,Pellegrin JL,Peuchant E,et al.Plasma lipids in HIV-infected patients:a prospective study in 95 patients[J].Eur J Clin Invest,1994,24(6):416-420.
  • 8Versluis AJ,Rensen PC,Rump ET,et al.Low-density lipoprotein receptor-mediated delivery of a lipophilic daunorubicin derivative to B16 tumours in mice using apolipoprotein Eenriched liposomes[J].Br J Cancer,1998,78 (12):1607-1614.
  • 9Romero EL,Morilla MJ,Bakas LS.Lipid vectors.New strategies for gene therapy[J].Medicina (B Aires),2001,61 (2):205-214.
  • 10Lian T,Ho RJ.Trends and developments in liposome drug delivery systems[J].J Pharm Sci,2001,90 (6):667-680.

共引文献21

同被引文献36

引证文献4

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部